Anika Therapeutics (ANIK) Net Shares Issued and Repurchased (2011 - 2026)
Anika Therapeutics' (ANIK) quarterly Net Shares Issued and Repurchased came in at $476221.0 in Q1 2026, up 120.09% year-over-year from $216376.0 in Q1 2025, and up 39.94% quarter-over-quarter from $340315.0 in Q4 2025.
Powered by 
Analysis
Anika Therapeutics (ANIK) Net Shares Issued and Repurchased (2011 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Net Shares Issued and Repurchased for 16 consecutive years, with $476221.0 the latest figure, recorded in Q1 2026.
- On a quarterly basis, Net Shares Issued and Repurchased rose 120.09% year-over-year to $476221.0 in Q1 2026; TTM through Mar 2026 was $476221.0, a 120.09% increase from a year earlier, with the FY2025 full-year figure at $340315.0, down 37.84% from the prior year.
- Net Shares Issued and Repurchased was $476221.0 for Q1 2026 at Anika Therapeutics, up from $340315.0 in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $553827.0 in Q4 2022 and troughed at $216376.0 in Q1 2025.
- A 5-year average of $413484.3 and a median of $416197.0 in 2022 frame the typical range for Net Shares Issued and Repurchased.
- Across the five-year window, Net Shares Issued and Repurchased plunged 49.32% in 2025 and soared 120.09% in 2026, its largest moves.
- Over 5 years, Net Shares Issued and Repurchased stood at $553827.0 in 2022, then fell by 26.89% to $404903.0 in 2023, then jumped by 35.21% to $547450.0 in 2024, then slumped by 37.84% to $340315.0 in 2025, then soared by 39.94% to $476221.0 in 2026.
- The last three Net Shares Issued and Repurchased figures came in at $476221.0 (Q1 2026), $340315.0 (Q4 2025), and $216376.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Anika Therapeutics | 277.93 Mn | 239.52 Mn | 21.24 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 476,221.00 |
| Dec 31, 2025 | 340,315.00 |
| Mar 31, 2025 | 216,376.00 |
| Dec 31, 2024 | 547,450.00 |
| Mar 31, 2024 | 426,925.00 |
| Dec 31, 2023 | 404,903.00 |
| Mar 31, 2023 | 339,145.00 |
| Dec 31, 2022 | 553,827.00 |
| Mar 31, 2022 | 416,197.00 |
| Dec 31, 2021 | 529,505.00 |
| Mar 31, 2021 | 421,463.00 |
| Dec 31, 2020 | 546,496.00 |
| Sep 30, 2020 | 85,345.00 |
| Jun 30, 2020 | 106,438.00 |
| Mar 31, 2020 | 210,775.00 |
| Dec 31, 2019 | 254,517.00 |
| Sep 30, 2019 | 87,250.00 |
| Jun 30, 2019 | 27,325.00 |
| Mar 31, 2019 | 104,292.00 |
| Dec 31, 2018 | 199,970.00 |